Dr. Lal PathLabs confirms compliance with SEBI regulations regarding depositories and participants for the quarter ended December 31, 2025. A certificate was received from MUFG Intime India Private Limited, Registrar & Share Transfer Agent (RTA), confirming adherence to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This announcement provides assurance of the company’s regulatory compliance.
Regulatory Compliance Confirmation
Dr. Lal PathLabs has announced its compliance with specific regulations related to depositories and participants. This confirmation follows the receipt of a certificate from MUFG Intime India Private Limited, the Registrar & Share Transfer Agent (RTA) for the company.
Compliance Details
The certificate confirms that Dr. Lal PathLabs has adhered to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This compliance is specifically for the quarter that concluded on December 31, 2025. MUFG Intime India Private Limited confirmed that no demat requests were received during this period, given the company does not have physical shares. This ensures all transactions are aligned with regulatory requirements.
Source: BSE
